Evolution and management of the pediatric multi-systemic inflammatory syndrome associated with SARS CoV-2 infection in a pediatric ICU in Lima, Peru
- Liliana Cieza-Yamunaqué,
- Ricardo Rodriguez-Portilla,
- Michael Baique-Sanchez,
- Edgar Coila-Paricahua,
- Claudia Guerra-Ríos,
- Patricia Llaque-Quiroz
- Hospital Nacional Edgardo Rebagliati Martins, EsSalud,
- Instituto Nacional de Salud del Niño San Borja,
- ,
- ,
- Hospital Daniel Alcides Carrión
Open access
Publication Information
Output type
Original language
SpanishPages from-to (Number of pages)
Pages 262-266 (5 pages)Journal (Volume, Issue Number)
Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo (Volume 14, Issue 3)Publication milestones
- Published - 11/2021
Publication status
ISSN
2225-5109Publication IDs
- Scopus: 85122975055
Abstract
Background: Pediatric Multisystemic Inflammatory Syndrome (SIMP) associated with SARS CoV2 seriously affects children. Objective: To describe the symptoms, treatment and evolution of SIMP in patients of a reference Pediatric Intensive Care Unit (PICU). Findings: 18 children were identified with a mean age of 8.76 years, 50% male, all with a positive serological test. The most frequent manifestations were: fever (100%), respiratory distress (94%), abdominal pain (89%), elevated C-reactive protein (average 21.8), thrombocytopenia (50%), pathological chest X-ray (89%) and depressed myocardial contractility (61%). 72% required invasive mechanical ventilation (average 3 days) and catecholamines; 89% used corticosteroids plus immunoglobulins. The average stay in the PICU was 5.5 days. One patient died of intracerebral hemorrhage. Conclusions: SIMP in PICU is characterized by fever, respiratory distress, abdominal pain, elevated inflammatory markers, and myocardial depression. Requiring corticosteroids, immunoglobulin and ventilatory support; presenting intermediate stay and low mortality.